Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 609

1.

ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.

Yaparpalvi R, Hong L, Mah D, Shen J, Mutyala S, Spierer M, Garg M, Guha C, Kalnicki S.

Radiother Oncol. 2008 Dec;89(3):347-52. doi: 10.1016/j.radonc.2008.07.025. Epub 2008 Aug 31.

PMID:
18762345
2.

Remarks on reporting and recording consistent with the ICRU reference dose.

Bratengeier K, Oechsner M, Gainey M, Flentje M.

Radiat Oncol. 2009 Oct 14;4:44. doi: 10.1186/1748-717X-4-44.

3.

Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.

Lee EK, Fox T, Crocker I.

Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):301-20. Epub 2005 Nov 14.

PMID:
16289912
4.

Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.

Dogan N, King S, Emami B, Mohideen N, Mirkovic N, Leybovich LB, Sethi A.

Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1480-91.

PMID:
14630288
5.

Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.

Martinez AA, Yan D, Lockman D, Brabbins D, Kota K, Sharpe M, Jaffray DA, Vicini F, Wong J.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1226-34.

PMID:
11483333
6.

Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.

Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):752-9.

PMID:
15183478
7.

Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.

Hein PA, Gladstone DJ, Bellerive MR, Hug EB.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1540-8.

PMID:
16029816
8.

Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.

Das IJ, Cheng CW, Chopra KL, Mitra RK, Srivastava SP, Glatstein E.

J Natl Cancer Inst. 2008 Mar 5;100(5):300-7. doi: 10.1093/jnci/djn020. Epub 2008 Feb 26.

9.

Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.

Mavroidis P, Ferreira BC, Shi C, Lind BK, Papanikolaou N.

Phys Med Biol. 2007 Jul 7;52(13):3817-36. Epub 2007 May 31.

PMID:
17664579
11.

Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes.

Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):274-81.

PMID:
16111597
12.

Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer.

Schwarz M, Alber M, Lebesque JV, Mijnheer BJ, Damen EM.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):561-70.

PMID:
15890601
13.

Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.

Fenoglietto P, Laliberte B, Allaw A, Ailleres N, Idri K, Hay MH, Moscardo CL, Gourgou S, Dubois JB, Azria D.

Radiother Oncol. 2008 Jul;88(1):77-87. doi: 10.1016/j.radonc.2007.12.011. Epub 2008 Jan 22.

PMID:
18215434
14.

IMRT of large fields: whole-abdomen irradiation.

Hong L, Alektiar K, Chui C, LoSasso T, Hunt M, Spirou S, Yang J, Amols H, Ling C, Fuks Z, Leibel S.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):278-89.

PMID:
12183002
16.

Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.

Lamers-Kuijper E, Schwarz M, Rasch C, Mijnheer B.

Med Dosim. 2007 Winter;32(4):237-45.

PMID:
17980823
17.

A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.

Lavrenkov K, Christian JA, Partridge M, Niotsikou E, Cook G, Parker M, Bedford JL, Brada M.

Radiother Oncol. 2007 May;83(2):156-62. Epub 2007 May 9.

PMID:
17493699
18.
19.

Importance of accurate dose calculations outside segment edges in intensity modulated radiotherapy treatment planning.

Schwarz M, Bos LJ, Mijnheer BJ, Lebesque JV, Damen EM.

Radiother Oncol. 2003 Dec;69(3):305-14.

PMID:
14644490
20.

Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.

Choi Y, Kim JK, Lee HS, Hur WJ, Chai GY, Kang KM.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):683-9. Epub 2005 May 31.

PMID:
15927412
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk